Krystal Biotech Inc. KRYS
$323.45
▼ -1.11% 24H
About
Krystal Biotech Inc. is a biotechnology company primarily focused on developing and commercializing gene therapy products for patients with rare dermatological conditions. Its innovative platform harnesses gene delivery technology to address unmet medical needs by developing a pipeline of products aimed at treating gen…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees295
TickerKRYS
Statistics
Market Cap$9.52B
Revenue (TTM)$389.1M
Net Income$204.8M
Net Margin52.6%
EPS$6.84
P/E43.04
P/S22.72
P/B7.41
EV/EBITDA46.52
ROE19.9%
Dividend Yield—
Price$323.45
Data: Twelve Data · Revenue = mcap / P/S